REGIONAL PRO-DRUG GENE-THERAPY - INTRAVENOUS ADMINISTRATION OF AN ADENOVIRAL VECTOR EXPRESSING THE ESCHERICHIA-COLI CYTOSINE DEAMINASE GENEAND SYSTEMIC ADMINISTRATION OF 5-FLUOROCYTOSINE SUPPRESSES GROWTH OF HEPATIC METASTASIS OF COLON-CARCINOMA
N. Topf et al., REGIONAL PRO-DRUG GENE-THERAPY - INTRAVENOUS ADMINISTRATION OF AN ADENOVIRAL VECTOR EXPRESSING THE ESCHERICHIA-COLI CYTOSINE DEAMINASE GENEAND SYSTEMIC ADMINISTRATION OF 5-FLUOROCYTOSINE SUPPRESSES GROWTH OF HEPATIC METASTASIS OF COLON-CARCINOMA, Gene therapy, 5(4), 1998, pp. 507-513
Citations number
30
Categorie Soggetti
Biothechnology & Applied Migrobiology","Genetics & Heredity",Biology,"Medicine, Research & Experimental
Direct administration of an adenoviral vector expressing the cytosine
deaminase gene (AdCMV.CD) to tumors of colon carcinoma cells, with con
comitant systemic administration of 5-fluorocytosine (5FC), results in
focal production of 5-fluorouracil (5FU) and suppression of tumor gro
wth. Based on the demonstration that in vivo adenovirus-mediated gene
transfer to intrahepatic tumors is relatively inefficient compared wit
h in vivo gene transfer to hepatocytes, we developed a 'regional' prod
rug strategy using in vivo Ad-mediated CD gene transfer to normal live
r, permitting hepatocytes to convert 5FC into 5FU to treat local metas
tasis effectively in a 'trans' fashion, To show that hepatocytes can g
enerate and export sufficient 5FU lo achieve this goal, primary rat he
patocytes were exposed to AdCMV. CD and 5FC. Evaluation of the superna
tants by spectrophotometry and by HPLC demonstrated significant conver
sion of 5FC into 5FU. When supernatants of hepatocytes exposed to AdCM
V.CD and 5FC were transferred to cultures of CT26 mouse colon carcinom
a cells, the CT26 Viability was reduced by 80%. To show that this regi
onal AdCMV.CD/5FC prodrug strategy can suppress tumor growth in vivo,
a model of metastatic colon carcinoma was established by injecting CT2
6 cells into the left lobe of the liver of syngeneic Balb/c mice. The
next day, AdCMV.CD was transferred to hepatocytes by intravenous admin
istration, and 5FC treatment was started the following day. Evaluation
of tumor growth after 15 days showed marked suppression of tumor grow
th in AdCMV.CD- and 5FC-treated animals compared to control groups (P
< 0.007). We conclude that primary hepatocytes are capable of converti
ng 5FC into 5FU and exporting sufficient amounts of 5FU to the local m
ilieu to suppress the growth of liver metastases of colon carcinoma ce
lls.